These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 8487051)
1. The Head and Neck Radiotherapy Questionnaire: a morbidity/quality-of-life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer. Browman GP; Levine MN; Hodson DI; Sathya J; Russell R; Skingley P; Cripps C; Eapen L; Girard A J Clin Oncol; 1993 May; 11(5):863-72. PubMed ID: 8487051 [TBL] [Abstract][Full Text] [Related]
2. Preliminary investigation of symptom distress in the head and neck patient population: validation of a measurement instrument. Jones HA; Hershock D; Machtay M; Chalian AA; Weber RS; Weinstein GS; Schumacher K; Kligerman MM; Berlin JA; Rosenthal DI Am J Clin Oncol; 2006 Apr; 29(2):158-62. PubMed ID: 16601435 [TBL] [Abstract][Full Text] [Related]
3. Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer. Browman GP; Cripps C; Hodson DI; Eapen L; Sathya J; Levine MN J Clin Oncol; 1994 Dec; 12(12):2648-53. PubMed ID: 7989940 [TBL] [Abstract][Full Text] [Related]
4. Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. Taylor SG; Murthy AK; Vannetzel JM; Colin P; Dray M; Caldarelli DD; Shott S; Vokes E; Showel JL; Hutchinson JC J Clin Oncol; 1994 Feb; 12(2):385-95. PubMed ID: 8113846 [TBL] [Abstract][Full Text] [Related]
5. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up. Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029 [TBL] [Abstract][Full Text] [Related]
6. Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination. List MA; Siston A; Haraf D; Schumm P; Kies M; Stenson K; Vokes EE J Clin Oncol; 1999 Mar; 17(3):1020-8. PubMed ID: 10071297 [TBL] [Abstract][Full Text] [Related]
7. Dose-finding study of docetaxel added to ifosfamide and cisplatin followed by concomitant capecitabine and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck. Recchia F; Saggio G; Cesta A; Amiconi G; di Blasio A; Candeloro G; Valeriani M; Tombolini V; Rea S Anticancer Res; 2006; 26(3B):2317-24. PubMed ID: 16821609 [TBL] [Abstract][Full Text] [Related]
8. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study. Leyvraz S; Pasche P; Bauer J; Bernasconi S; Monnier P J Clin Oncol; 1994 Sep; 12(9):1876-85. PubMed ID: 8083711 [TBL] [Abstract][Full Text] [Related]
9. Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia. Ringash J; Warde P; Lockwood G; O'Sullivan B; Waldron J; Cummings B Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1403-7. PubMed ID: 15817343 [TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study. Ghi MG; Paccagnella A; D'Amanzo P; Mione CA; Fasan S; Paro S; Mastromauro C; Carnuccio R; Turcato G; Gatti C; Pallini A; Nascimben O; Biason R; Oniga F; Medici M; Rossi F; Fila G Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):481-7. PubMed ID: 15145166 [TBL] [Abstract][Full Text] [Related]
11. Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire. Epstein JB; Beaumont JL; Gwede CK; Murphy B; Garden AS; Meredith R; Le QT; Brizel D; Isitt J; Cella D Cancer; 2007 May; 109(9):1914-22. PubMed ID: 17377917 [TBL] [Abstract][Full Text] [Related]
12. Tirapazamine, Cisplatin, and Radiation versus Fluorouracil, Cisplatin, and Radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02). Rischin D; Peters L; Fisher R; Macann A; Denham J; Poulsen M; Jackson M; Kenny L; Penniment M; Corry J; Lamb D; McClure B J Clin Oncol; 2005 Jan; 23(1):79-87. PubMed ID: 15625362 [TBL] [Abstract][Full Text] [Related]
13. Toxic cure: Hyperfractionated radiotherapy with concurrent cisplatin and fluorouracil for Stage III and IVA head-and-neck cancer in the community. Maguire PD; Meyerson MB; Neal CR; Hamann MS; Bost AL; Anagnost JW; Ungaro PC; Pollock HD; McMurray JE; Wilson EP; Kotwall CA Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):698-704. PubMed ID: 14967423 [TBL] [Abstract][Full Text] [Related]
14. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma. Brizel DM; Murphy BA; Rosenthal DI; Pandya KJ; Glück S; Brizel HE; Meredith RF; Berger D; Chen MG; Mendenhall W J Clin Oncol; 2008 May; 26(15):2489-96. PubMed ID: 18487568 [TBL] [Abstract][Full Text] [Related]
15. Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracil. Wibault P; Bensmaine MA; de Forni M; Armand JP; Tellez Bernal E; Guillot T; Recondo G; Domenge C; Janot F; Borel C; Luboinski B; Eschwege F; Cvitkovic E J Clin Oncol; 1996 Apr; 14(4):1192-200. PubMed ID: 8648374 [TBL] [Abstract][Full Text] [Related]
16. Religious belief as a coping strategy: an explorative trial in patients irradiated for head-and-neck cancer. Becker G; Momm F; Xander C; Bartelt S; Zander-Heinz A; Budischewski K; Domin C; Henke M; Adamietz IA; Frommhold H Strahlenther Onkol; 2006 May; 182(5):270-6. PubMed ID: 16673060 [TBL] [Abstract][Full Text] [Related]
17. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma. Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506 [TBL] [Abstract][Full Text] [Related]
18. Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer. Kies MS; Haraf DJ; Rosen F; Stenson K; List M; Brockstein B; Chung T; Mittal BB; Pelzer H; Portugal L; Rademaker A; Weichselbaum R; Vokes EE J Clin Oncol; 2001 Apr; 19(7):1961-9. PubMed ID: 11283128 [TBL] [Abstract][Full Text] [Related]
19. Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer. Vokes EE; Haraf DJ; Mick R; McEvilly JM; Weichselbaum RR J Clin Oncol; 1994 Nov; 12(11):2351-9. PubMed ID: 7525886 [TBL] [Abstract][Full Text] [Related]
20. Acute and chronic changes in swallowing and quality of life following intraarterial chemoradiation for organ preservation in patients with advanced head and neck cancer. Murry T; Madasu R; Martin A; Robbins KT Head Neck; 1998 Jan; 20(1):31-7. PubMed ID: 9464950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]